Q2 Holdings

Q2 did about $795M TTM revenue and trades at 93.0x trailing earnings.

If you own QTWO, the stock is priced like perfection on sub-$1B sales—watch that quarterly prints are ~¼ of FY, not mislabeled nine-month totals.

qtwo

technology · software mid cap updated jan 30, 2026
$65.07
market cap ~$4B · 52-week range $40–$104
xvary composite: 55 / 100 · below average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Q2 sells software that helps banks run digital banking, lending, and leasing on phones and computers.
how it gets paid
Last year Q2 Holdings made $795M in revenue. Digital banking platform was the main engine at $0.23B, or ~29% of sales.
why it's growing
Revenue grew 14.1% last year. A typical quarter is on the order of ~$199M (≈¼ of $795M)—not $587M, which was a bad scrape vs TTM.
what just happened
Q2 beat on profit with filing EPS ~$0.49, quarterly revenue ~$199M, and 53.6% gross margin.
At a glance
B+ balance sheet — decent shape, but not bulletproof
40/100 earnings predictability — expect surprises
93.0x trailing p/e — you're paying up for this one
8.0% return on capital — nothing to write home about
xvary composite: 55/100 — below average
What they do
Q2 sells software that helps banks run digital banking, lending, and leasing on phones and computers.
1,200 financial institutions use Q2. 460 of them buy the digital banking platform. Leaving means ripping out the software backbone your staff and customers already use. That platform handled 24.7 million accounts and $3.3 trillion in transactions in 2024. Your bank does not swap that out on a lunch break.
software mid-cap fintech digital-banking saas
How they make money
$795M revenue (TTM / last-year scale in this feed—same ~$795M as hero) · grew +14.1% last year
Digital banking platform
$0.23B
+12.0%
Digital lending
$0.18B
+15.0%
Risk and fraud tools
$0.16B
+14.0%
Cash management
$0.12B
+10.0%
Other services
$0.105B
+18.0%
The products that matter
digital banking software
Digital Banking Platform
core platform · company revenue $795M
this is the front door for the franchise. q2 generated $795M last year and carries a $2.5B backlog, but this page does not disclose this product's exact revenue share.
core
api and developer tools
Q2 Advancement Suite
api + sdk layer · r&d ~$150M
the job here is deeper integration. with about $150M going into r&d annually, you want this layer creating stickier clients and more cross-sell, not just more product surface area.
integration
loan and pricing workflow software
Lending and Relationship Pricing
cross-sell engine · margin relevance
this portfolio matters because wallet share inside existing clients is cheaper than winning new banks. on a ~10% net margin in this feed, cross-sell efficiency matters more than product sprawl.
cross-sell
modular banking platform
Helix
flexible deployment · backlog support
helix is aimed at institutions that want to add applications onto existing systems. that supports the $2.5B backlog story, but there is no standalone revenue number here, so you should treat it as a promise with real contracts behind it, not a finished proof point.
platform bet
Key numbers
$795M
revenue (TTM · feed)
Same scale as “last year” in basics—whole business today. Wall Street is paying 93.0x earnings for a company under $1B in sales.
93.0x
trailing p/e
You are paying 93 years of earnings for one year of profit. The market expects clean execution.
$3.3T
transaction volume
That volume shows how embedded the platform is. Banks do not casually move $3.3T of traffic.
1,200
customers
A 1,200-customer base gives Q2 a wide sales surface. More banks mean more chances to upsell software.
Financial health
B+
strength
  • balance sheet grade B+ — solid but not elite
  • risk rank 3 — safer than 50% of stocks
  • price stability 20 / 100
  • net profit margin 10.0% — keeps 10 cents of every dollar in revenue
  • return on equity 12% — $0.12 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
Total return vs. market

You invested $10,000 in QTWO 3 years ago → it's now worth $21,170.

The index would have given you $14,770.

source: institutional data · total return
What just happened
beat estimates
Q2 beat on profit with ~$199M quarterly revenue (filing) and 53.6% gross margin—not $587M as one quarter.
Vendor screens (e.g. Yahoo) showed $0.30 actual vs $0.15 expected—often a different EPS basis or restatement window than EDGAR. The filing print used on-page is ~$0.49 EPS and 53.6% gross margin; match diluted vs adjusted and the exact quarter label before merging the two.
$199M
revenue
$0.49
eps
53.6%
gross margin
the number that mattered
~$0.49 quarterly EPS (EDGAR) vs a lower consensus print—on 93x earnings, beats need to be real, and revenue labels need to match ~$199M Q scale.
source: company earnings report, 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the #1 risk is signed bank contracts turning into slow, low-margin implementations.

med
implementation slippage
a $2.5B backlog sounds great until delivery slows. with backlog running at more than three times annual revenue, the stock needs that pipeline to convert on schedule.
if conversion slips, the path to $870M in revenue gets harder and the multiple loses one of its main supports.
med
margin stall
~10% net margin in this feed is positive, but it is not much cushion for a software name trading at 93.0x trailing earnings. if costs stay sticky, backlog growth can still feel underwhelming to shareholders.
this is the valuation trap: revenue can rise and the stock can still disappoint if profit does not scale with it.
med
bank tech budget pressure
q2 sells into financial institutions. when banks get cautious, software rollouts, expansions, and implementation timing can stretch even if clients do not disappear.
that would pressure a business expected to grow from $795M to $870M while still funding about $150M a year in r&d.
a 20 / 100 price stability score, 93.0x trailing p/e, and a ~10% net margin leave little room for a slow rollout or a cost surprise.
source: institutional data · regulatory filings · risk analysis
Pay attention to
risk
backlog conversion
$2.5B of backlog is the bull-case anchor. if that pipeline converts slowly, the stock stops looking like a growth story and starts looking expensive.
calendar
2026 guidance updates
the next guide matters because wall street already expects $870M in revenue and $0.90 in EPS. guidance is where management tells you whether the cleanup is on schedule.
metric
margin improvement
~10% net margin is positive, not impressive. this number needs to move up if the premium valuation is going to hold.
trend
r&d payoff
about $150M a year goes into r&d. the trend to watch is whether that spend shows up in adoption, cross-sell, and cleaner profitability.
Analyst rankings
short-term outlook
average
momentum score 3. in human-speak, analysts see a normal setup here, not a screaming short-term signal.
risk profile
average
stability score 3 means middle-of-the-pack safety. the catch is that the separate 20 / 100 price stability score says the stock itself still swings hard.
chart momentum
average
technical score 3 means the chart is not sending a strong message either way. this is a stock waiting for execution proof.
earnings predictability
40 / 100
earnings predictability is weak. plain english: this is not the kind of company where you assume quarterly numbers will land quietly.
source: institutional data
Institutional activity

institutions have been net buying for 3 consecutive quarters — 181 buyers vs. 171 sellers in 3q2025. total institutional holdings: 66.9M shares. net buying for 3 quarters.

source: institutional data
Price targets
3-5 year target range
$55 $133
$65 current price
$94 target midpoint · +44% from current · 3-5yr high: $125 (+90% · 18% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
QTWO
xvary deep dive
qtwo
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it